Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
2.
Rev. méd. Chile ; 149(9): 1360-1371, sept. 2021. tab, ilus
Artigo em Espanhol | LILACS | ID: biblio-1389596

RESUMO

Non-alcoholic fatty liver disease (NAFLD) has a high prevalence and risk of progression to cirrhosis and other complications in patients with type 2 diabetes mellitus (T2DM). Likewise, the presence of NAFLD implies a high risk of developing T2DM, determining a bidirectional relationship between them. The diabetology and hepatology societies, developed a joint initiative aiming to unify criteria, reviewing the definitions, diagnostic criteria, risk stratification, treatment, and follow-up of patients with NAFLD and T2DM. The key questions to be discussed were defined by a panel of specialists in diabetology and hepatology. The Delphi methodology was used to reach consensus on the respective recommendations. Based on the discussion generated among the experts, diagnostic and treatment algorithms were proposed, as well as an indication for referral and the role of the different specialists involved in the management of these patients. Strengthening multidisciplinary work with patients with NAFLD and T2DM will allow the early recognition of the disease, the prevention of the progression to cirrhosis, and reducing the associated complications.


Assuntos
Humanos , Diabetes Mellitus Tipo 2/complicações , Hepatopatia Gordurosa não Alcoólica/complicações , Gastroenterologia , Chile/epidemiologia
3.
Rev. Hosp. Clin. Univ. Chile ; 12(2): 83-88, 2001.
Artigo em Espanhol | LILACS | ID: lil-300231

RESUMO

Esta revisión actualiza los conocimientos más recientes sobre los Probióticos, como hidratos de carbono, proteínas, fibras y otros sustratos de la flora intestinal y los Probióticos, microrganismos vivos que ejercen un efecto beneficioso en la salud al poblar el instestino. Estos últimos son objetos del estudio. Los más estudiados han sido a base de Lactobacillus, Enterococcus faecium, Bifidobacterium, Streptococcus, y Saccharomyces boulardii (un hongo). Se estima que los resultados mejor demostrado son: sobrevivencia en el instestino, adhesión a epitelio y colonización intestinal en el largo plazo, mejor tolerancia a yogurt, prevención y acortamiento de la diarrea postantibióticos (Saccharomyces boulardii y Enterococcus faecium), prevención de recurrencias de cuadros intestinales por Clostridium difficile (con Saccharomyces boulardii) y acortamiento de la diarrea por Rotavirus (con leches fermentadas conteniendo Lactobacillus rhamnosus GG). Se mencionan otras posibles circuntancias de su utilidad, como transtornos funcionales, enfermedades intestinales inflamatorias y neoplásicas


Assuntos
Humanos , Intestinos , Lactobacillus , Probióticos/farmacologia , Bifidobacterium , Colite Ulcerativa , Neoplasias do Colo , Diarreia , Sistema Imunitário , Probióticos/classificação , Probióticos/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA